Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 09, 2026 09:00 ET | Source: Junshi Biosciences

Junshi Biosciences Announces NMPA Acceptance of New Drug Applications for Toripalimab Injection (Subcutaneous) Across 12 Indications

NDAs for Toripalimab Injection (Subcutaneous) Across 12 Indications accepted by the NMPA
November 24, 2025 20:24 ET | Source: Junshi Biosciences

Junshi Biosciences Announces Primary Endpoints Met in JS001sc’s Phase 3 Study for the 1ST-line Treatment of NSQ-NSCLC

The phase 3 study of toripalimab's subcutaneous injection (JS001sc) has met primary endpoints